Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma

Background: Lenvatinib combined with a PD-1 inhibitor has obtained a satisfactory antitumor effect in several solid tumors. However, the efficacy and tumor response of lenvatinib with a PD-1 inhibitor in advanced intrahepatic cholangiocarcinoma still need further exploration. Methods: This is a sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lulu, Huang, Jingzheng, Wang, Linling, Ren, Wenrui, Tian, Hao, Hu, Anhong, Liang, Jun, Jiao, Yuqing, Li, Yali, Zhou, Qunfang, Zhang, Wenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198573/
https://www.ncbi.nlm.nih.gov/pubmed/35721133
http://dx.doi.org/10.3389/fphar.2022.894407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198573/
https://www.ncbi.nlm.nih.gov/pubmed/35721133
http://dx.doi.org/10.3389/fphar.2022.894407

Ejemplares similares